Pressure to publish not to blame for misconduct, says new study

A new study suggests that much of what we think about misconduct — including the idea that it is linked to the unrelenting pressure on scientists to publish high-profile papers — is incorrect. In a new paper out today in PLOS ONE [see update at end of post], Daniele Fanelli, Rodrigo Costas, and Vincent Larivière performed a retrospective analysis of … Continue reading Pressure to publish not to blame for misconduct, says new study

Expression of concern opens floodgates of controversy over lead in water supply

An expression of concern has been published on a paper that taps into a decades-long fight over how to remove lead from the water supply. The paper in question, published in the Journal American Water Works Association, supports the safety of a common but frequently criticized way of incrementally removing lead pipes. The expression of concern came after years of … Continue reading Expression of concern opens floodgates of controversy over lead in water supply

Troubled article ranking business schools earns expression of concern

An article that ranked University of Missouri-Kansas City number one in an area of business school training is set to receive an expression of concern. The move follows months of questions over the ranking’s legitimacy, following revelations such as a relationship between the authors and both the school and its top ranked researcher in the … Continue reading Troubled article ranking business schools earns expression of concern

WordPress parent company wins suit fighting false DMCA copyright claims

In late 2013, we filed suit along with Automattic, the parent company of our blogging platform WordPress, against someone allegedly at a news service in India who falsely claimed that we had violated its copyright. Last week, we were pleased to learn Automattic won a similar case against a group that tried to censor another … Continue reading WordPress parent company wins suit fighting false DMCA copyright claims

“Genuine error” sees expression of concern for vision loss paper

A duplicated figure has resulted in an expression of concern for a paper in the American Journal of Pathology on a treatment for ocular neovascularization, which causes vision loss. According to the notice, the corresponding author, David Shima, now at University College London, brought his concern to the journal. He called it a “genuine error” and … Continue reading “Genuine error” sees expression of concern for vision loss paper

Bad Memory? Repressed sexual abuse memory paper retracted for data inconsistencies

The journal Memory has retracted a paper on repressed sexual abuse after a protracted dispute between the authors and an institutional investigation in The Netherlands that led to no findings of misconduct against the first author, Elke Geraerts  — a rising star in the field of social psychology. (The title of hers TEDx talk, by … Continue reading Bad Memory? Repressed sexual abuse memory paper retracted for data inconsistencies

Journal expresses concern over flawed multiple sclerosis treatment guideline

The journal Neurology has issued an Expression of Concern over recommendations it published earlier this year regarding the treatment of multiple sclerosis. The journal’s website received multiple comments from clinicians expressing their own concern about the flawed recommendation, which was published as part of a paper titled “The American Academy of Neurology’s Top Five Choosing Wisely … Continue reading Journal expresses concern over flawed multiple sclerosis treatment guideline

Trial irregularities earn Lancet study of potential weight loss drug tesofensine Expression of Concern

A potential weight loss drug has been dealt what could be a serious setback after regulators found problems at two trial sites. While awaiting a final report, The Lancet, which published a study of the drug, tesofensine, has issued an Expression of Concern:

Study of blood pressure drug valsartan retracted

Hiroaki Matsubara, a prominent cardiologist with five Expressions of Concern and two retractions for his CV, has another retraction. As Larry Husten, who first reported the retraction at Forbes, notes, the notice for 2009’s “Effects of valsartan on morbidity and mortality in uncontrolled hypertensive patients with high cardiovascular risks: KYOTO HEART Study,” which appeared in … Continue reading Study of blood pressure drug valsartan retracted